+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Oral Vaccine"

Dog Vaccine - Global Strategic Business Report - Product Thumbnail Image

Dog Vaccine - Global Strategic Business Report

  • Report
  • August 2026
  • 576 Pages
  • Global
From
Rotavirus Prophylaxis Market Report 2026 - Product Thumbnail Image

Rotavirus Prophylaxis Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
From
From
From
From
From
Dengue Vaccine Market Opportunities and Strategies to 2034 - Product Thumbnail Image

Dengue Vaccine Market Opportunities and Strategies to 2034

  • Report
  • March 2025
  • 294 Pages
  • Global
From
Nasal Vaccines: Global Markets and Pipeline Analysis - Product Thumbnail Image

Nasal Vaccines: Global Markets and Pipeline Analysis

  • Report
  • December 2022
  • 78 Pages
  • Global
From
Loading Indicator

The Oral Vaccine market is a subset of the larger Vaccines market, which is focused on the development and distribution of vaccines to prevent and treat infectious diseases. Oral Vaccines are administered orally, rather than through injection, and are typically used to protect against gastrointestinal infections. These vaccines are often used in developing countries, where access to injection-based vaccines may be limited. Oral Vaccines are also used in certain circumstances where injection-based vaccines may not be suitable, such as in the elderly or immunocompromised individuals. Oral Vaccines are typically composed of weakened or killed pathogens, which stimulate the body’s immune system to produce antibodies against the disease. These vaccines are typically administered in multiple doses, and may require booster shots to maintain immunity. Some companies in the Oral Vaccine market include GlaxoSmithKline, Merck, Sanofi, Pfizer, and Johnson & Johnson. Show Less Read more